Experimentica
Ophthalmology-focused preclinical CRO offering retinal and anterior segment disease models, ocular dosing and functional readouts.
111 contract research organizations in our directory work with Mouse, across 17 countries. 61 report GLP capability and 21 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
The mouse is the most widely used species in preclinical research, and the default for discovery pharmacology. Its strengths are genetics and scale: inbred strains give low variability, genetically engineered and humanized mice make it possible to model human targets and disease, and small size keeps compound requirements low.
Mouse work at CROs covers oncology (xenograft, syngeneic and PDX models), metabolic disease, neurodegeneration and other CNS models, immunology and infectious disease, as well as early PK. Small blood volume limits serial sampling, so PK designs rely on composite sampling or microsampling.
Strain, vendor, sex and age affect results as much as the model name. Ask exactly which background strain a lab uses and whether it breeds models in-house or buys them in, especially for genetically engineered lines.
Showing 111 CROs. Order rotates daily so no lab is permanently listed first.
Ophthalmology-focused preclinical CRO offering retinal and anterior segment disease models, ocular dosing and functional readouts.
Preclinical CRO focused on rodent models of autoimmune and inflammatory disease, such as EAE, arthritis and colitis, with supporting histology, cytokine analysis and flow cytometry.
OECD GLP-certified preclinical CRO near Bengaluru providing regulatory toxicology for pharmaceuticals, biologics, devices and chemicals.
Preclinical CRO offering in vivo pharmacology, toxicology, and surgical services.
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
Edmonton CRO providing anti-infective drug discovery support, including in vivo infection models and pharmacokinetics.
Korean nonclinical CRO providing early PK, TK and bioanalytical method development and sample analysis.
Preclinical research company specializing in wound healing, biofilm and infection models for drugs and medical devices, including custom surgical models and electron microscopy.
Preclinical CRO offering discovery, DMPK, toxicology, surgical models, and specialty pathology.
French preclinical CRO specializing in bone, joint and inflammatory disease models with histology and imaging readouts.
In vivo pharmacology CRO near Philadelphia running a broad catalog of efficacy models across CNS, pain, metabolic and inflammatory disease.
Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.
Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.
Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.
Montreal-based neuroscience CRO combining neurodegenerative disease models with MRI imaging, quantitative neuropathology and image analysis.
Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.
Contract vivarium operator providing turnkey animal housing, husbandry, veterinary and technical research services for biotech teams, with in vivo study support.
Bay Area preclinical CRO offering GLP and non-GLP toxicology, pharmacology and efficacy models with an in-house histopathology lab, including tissue cross-reactivity and histomorphometry.
Michigan CRO offering in vivo ADME and pharmacokinetics, LC-MS/MS bioanalysis and biochemistry, with a niche in ocular drug development.
Specialty preclinical CRO focused on hearing research, offering ototoxicity, otoprotection and auditory efficacy studies.
St. Louis area CRO providing toxicology, pharmacokinetic and bioanalytical services, including inhalation work.
Shanghai oncology CRO with patient-derived xenograft and other tumor models for efficacy studies.
Independent nonprofit contract research organization with capabilities including inhalation toxicology and high-containment infectious disease research.
Preclinical CRO in the Research Triangle specializing in ophthalmic disease models, ocular dosing and retinal function readouts.
Ophthalmology-focused preclinical CRO offering ocular efficacy models, formulation screening, ocular PK and tolerability studies.
Israeli preclinical CRO offering in vivo pharmacology and disease model studies.
Integrated CRO-CDMO in India whose discovery biology group provides in vivo pharmacology, DMPK and bioanalysis for small molecule programs.
Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.
Preclinical in vivo pharmacology with CNS/behavioral expertise and multiple disease models.
With over 15 years of hands-on preclinical surgical experience, I deliver expert-level surgical support for in vivo studies across a broad range of therapeutic areas. I specialize in CNS drug delivery in nonhuman…
Lyon oncology CRO providing in vitro and in vivo proof-of-concept studies for anticancer agents, including resistant tumor models.
Finnish preclinical CRO focused on bone and joint disease, bone metastasis and oncology models, including osteoarthritis and osteoporosis efficacy studies.
Integrated CRO/CDMO spanning preclinical to early clinical, including safety assessment and bioanalysis.
Independent nonprofit research institute with a national primate research center and high-containment labs, offering contract infectious disease, vaccine and NHP studies.
Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.
Global preclinical/clinical CRO with extensive safety assessment, pharmacology, and discovery services.
Government-funded Korean research institute providing GLP nonclinical safety studies, including inhalation toxicology, safety pharmacology and reproductive toxicity.
Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.
Nonclinical CRO supporting infectious disease and other in vivo studies; bioanalysis and pathology support.
Indian GLP-certified preclinical CRO providing toxicology and safety studies.
Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.
Tokyo CRO known for NASH/MASH and fibrosis mouse models, with efficacy studies across liver, kidney and metabolic disease.
Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.
French CRO combining early clinical development with preclinical pharmacology, offering CNS and cardiovascular safety pharmacology and translational neuroscience models.
German CRO offering integrated discovery, DMPK, bioanalysis and early development services across sites in Germany and France.
Hyderabad discovery services company offering biology and DMPK support alongside chemistry.
French neuroscience CRO dedicated to in vitro and in vivo models of neurodegenerative and neurological disease, with a US office.
Bengaluru preclinical CRO providing pharmacology, pharmacokinetic and toxicology studies.
French CRO specializing in in vivo infection models for antibacterial and antifungal drug development.
Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.
Specialty CRO focused on preclinical kidney disease models and renal pathology for nephrology drug programs.
French neuroscience CRO offering in vitro and in vivo models for neurological and neurodegenerative drug discovery.
French preclinical CRO offering in vivo pharmacology in neuroscience, pain and dermatology, plus related safety studies.
Berlin oncology CRO with a large collection of patient-derived xenograft models for in vivo efficacy and biomarker studies.
Independent Danish CRO focused on early in vivo pharmacology in rodents, with particular expertise in mouse cancer and immuno-oncology models.
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
Preclinical efficacy CRO in the Boston area running predictive animal models across inflammation, mucositis, oncology-supportive care and other indications for biotech and pharma sponsors.
Texas preclinical CRO offering xenograft and other oncology models, efficacy, pharmacology and toxicology studies.
Swedish CRO specializing in rodent models of arthritis, autoimmunity and inflammation.
San Diego oncology CRO offering patient-derived and orthotopic tumor models for in vivo efficacy and translational studies.
Beijing-based company providing genetically engineered and humanized mouse models with in vivo pharmacology services, especially for oncology and immunology antibody programs.
Preclinical CRO in Northern Ireland, part of QIMA Life Sciences, running non-GLP rodent PK, dose range finding, biodistribution and disease model studies.
French translational oncology CRO built around patient-derived xenograft models, with drug response and biomarker discovery services.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
Animal model company offering custom genetically engineered rodents together with in vivo pharmacology and AAV services, with operations in the US and China.
Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.
Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.
Preclinical in vivo pharmacology and toxicology with aerosol/inhalation expertise.
Nonprofit mouse genetics institute offering contract in vivo pharmacology using its own strains and humanized and PDX models across oncology, neuroscience, metabolism and immunology.
Polish drug discovery CRO providing integrated chemistry, biology, DMPK and translational research services.
Contract testing laboratory providing GLP toxicology, analytical and bioanalytical chemistry for pharmaceutical, chemical, agrochemical, consumer and food ingredient sponsors.
Fraunhofer institute for toxicology and experimental medicine providing GLP inhalation toxicology, respiratory disease models and translational research under contract.
Preclinical GLP toxicology and safety pharmacology across small and large species.
GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…
Large CRO with global preclinical safety assessment, DMPK, and bioanalytical services.
Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.
Lyon-based company creating genetically engineered and humanized rodent models, with catalog models and in vivo research services.
Minnesota company providing preclinical services and reagents for oncolytic virus, gene and cell therapy programs, including reporter imaging and efficacy models.
Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.
Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.
Maryland CRO specializing in infectious disease and vaccine research, offering in vitro and in vivo efficacy models and immunological assays.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.
Preclinical CNS CRO offering behavioral pharmacology, translational neuroscience, EEG and disease models for psychiatric and neurological programs.
German preclinical CRO offering in vivo pharmacology, pharmacokinetic and exploratory safety studies.
Danish preclinical imaging CRO offering PET, SPECT, CT and MRI studies, radiopharmaceutical development support and oncology efficacy models.
Vector design and manufacturing company that also offers AAV biodistribution profiling services, including barcoded multiplex studies in rodents and NHPs.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Munich-area contract laboratory providing GLP toxicology, genetic toxicology, biocompatibility and microbiology testing for pharmaceutical, chemical and medical device sponsors.
Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.
CRO providing DMPK, bioanalysis, toxicology, and related preclinical services.
Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.
Japanese company offering humanized-liver mice and contract studies for human metabolism, DMPK and hepatitis research.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Indian GLP test facility offering regulatory toxicology studies for chemicals, agrochemicals and pharmaceuticals.
North Carolina CRO specializing in immunotoxicology, including GLP immune function assays for drugs, chemicals and biologics.
Australian bioanalytical and toxicology CRO with OECD GLP labs, supporting nonclinical toxicology and clinical bioanalysis.
Houston preclinical CRO near the Texas Medical Center with an AAALAC-accredited mouse vivarium, in vivo pharmacology and flexible lab space.
Small niche oncology pharmacology CRO validating in vivo efficacy of cancer therapies in clinically predictive models.
Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.
Korean non-clinical CRO focused on efficacy testing of new drug candidates, with research facilities in Songdo, Incheon.
Preclinical CRO near Toulouse specializing in metabolic disease pharmacology, including obesity, diabetes and NASH/MASH models.
Bengaluru CRDMO offering discovery services including DMPK, safety and bioanalysis alongside development and manufacturing.
Translational neuroscience CRO with sites in the UK, Ireland and Canada offering CNS disease models, EEG and behavioral pharmacology.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
Non-clinical CRO near Milan and part of the NMS Group, offering GLP safety assessment and toxicology, safety pharmacology and preclinical regulatory consulting to move candidates toward IND/CTA.
French CRO focused on neurodegeneration and brain aging, offering in vivo models and readouts for Alzheimer's and related diseases.
Not-for-profit research institute in Birmingham, Alabama providing contract drug discovery and preclinical development, including infectious disease and BSL-3 work, oncology models, ADME, bioanalysis, toxicology and…
Japanese preclinical CRO offering GLP safety and efficacy studies for drugs, devices and regenerative products, with long minipig experience.
South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.